Controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer - Reply

被引：2
|
作者：
Schellhammer, PF
Soloway, MS
Vogelzang, NJ
Sarosdy, MF
Jones, JA
Kolvenbag, GJCM
机构：
[1] UNIV MIAMI,SCH MED,MIAMI,FL
[2] UNIV CHICAGO,CHICAGO,IL 60637
[3] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX
[4] ZENECA PHARMACEUT,WILMINGTON,DE
来源：
UROLOGY | 1996年 / 48卷 / 04期
关键词：
D O I：
10.1016/S0090-4295(96)80034-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：662 / 663
页数：2
相关论文
共 50 条
  • [41] ANAMEM: PROSPECTIVE AND OBSERVATIONAL STUDY TO EVALUATE COGNITIVE CHANGES IN PROSTATE CANCER PATIENTS UNDERGOING LUTEINIZING HORMONE-RELEASING HORMONE ANALOGUE TREATMENT
    Morote, Juan
    Tabernero, Angel
    Luis Alvarez-Ossorio, Jose
    Pablo Ciria, Juan
    Luis Dominguez-Escrig, Jose
    Vazquez, Fernando
    Angulo, Javier C.
    Javier Lopez, Francisco
    De la Iglesia, Ramon
    Romero, Jesus
    JOURNAL OF UROLOGY, 2015, 193 (04): : E929 - E929
  • [42] Luteinizing hormone-releasing hormone targeted superparamagnetic gold nanoshells for a combination therapy of hyperthermia and controlled drug delivery
    Mohammad, Faruq
    Al-Lohedan, Hamad A.
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2017, 76 : 692 - 700
  • [43] Phase II trial of decapeptyl (D-TRP-6), a potent luteinizing hormone-releasing hormone analogue in untreated advanced breast cancer
    GarciaGiralt, E
    Beuzeboc, P
    Dieras, V
    Dorval, T
    Jouve, M
    Livartowski, A
    Palangie, T
    Scholl, S
    Pouillart, P
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (05): : 455 - 458
  • [44] Efficacy of a Second Line Luteinizing Hormone-Releasing Hormone Agonist After Advanced Prostate Cancer Biochemical Recurrence
    Lawrentschuk, Nathan
    Fernandes, Kimberly
    Bell, David
    Barkin, Jack
    Fleshner, Neil
    JOURNAL OF UROLOGY, 2011, 185 (03): : 848 - 854
  • [45] Cytotoxic luteinizing hormone-releasing hormone conjugates and their use in gynecological cancer therapy
    Gründker, C
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (05) : 569 - 572
  • [46] LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONIST REDUCE SERUM ADRENAL ANDROGEN LEVELS IN PROSTATE CANCER PATIENTS
    Miyazawa, Yoshiyuki
    Kato, Haruo
    Furuya, Yosuke
    Nitta, Takashi
    Sekine, Yoshitaka
    Koike, Hidekazu
    Matsui, Hiroshi
    Shibata, Yasuhiro
    Ito, Kazuto
    Suzuki, Kazuhiro
    JOURNAL OF UROLOGY, 2016, 195 (04): : E675 - E676
  • [47] Luteinizing hormone-releasing hormone agonists for prostate cancer patients: routine clinical practice of Russian cancer urologists
    Matveev, V. B.
    Alekseev, B. Ya
    Kamolov, B. Sh
    Markova, A. S.
    ONKOUROLOGIYA, 2021, 17 (02): : 83 - 92
  • [48] Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial
    Green, HJ
    Pakenham, KI
    Headley, BC
    Yaxley, J
    Nicol, DL
    Mactaggart, PN
    Swanson, C
    Watson, RB
    Gardiner, RA
    BJU INTERNATIONAL, 2002, 90 (04) : 427 - 432
  • [49] Testosterone Suppression with Luteinizing Hormone-Releasing Hormone (LHRH) Agonists in Patients Receiving Radiotherapy for Prostate Cancer
    Wilke, Derek
    Patil, Nikhilesh
    Hollenhorst, Helmut
    Bowes, David
    Rutledge, Robert
    Ago, Casely
    PHARMACOTHERAPY, 2018, 38 (03): : 327 - 333
  • [50] NATIONAL-CANCER-INSTITUTE STUDY OF LUTEINIZING-HORMONE-RELEASING HORMONE PLUS FLUTAMIDE VERSUS LUTEINIZING-HORMONE-RELEASING HORMONE PLUS PLACEBO
    BENSON, RC
    CRAWFORD, ED
    EISENBERGER, MA
    MCLEOD, DG
    SPAULDING, JT
    DORR, FA
    SEMINARS IN ONCOLOGY, 1991, 18 (05) : 9 - 12
12345